Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaAlan J. Thompson, Jeffrey A. Cohen, Brenda Banwell et al.|The Lancet Neurology|2017Cited by 8k
Defining the clinical course of multiple sclerosisFred Lublin, Chris H. Polman, Stephen C. Reingold et al.|Neurology|2014Cited by 3.1k
Ocrelizumab versus Placebo in Primary Progressive Multiple SclerosisXavier Montalbán, Jerry S. Wolinsky, Stephen L. Hauser et al.|New England Journal of Medicine|2016Cited by 1.9k
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised studyGiancarlo Comi, O. R. Hommes, Massimo Filippi et al.|The Lancet|2001Cited by 1.1k
Oral Fingolimod (FTY720) for Relapsing Multiple SclerosisLudwig Kappos, Ernst W. Radue, Jack P. Antel et al.|New England Journal of Medicine|2006Cited by 1.1k